RECRUITING

Genetic Testing Decision Aid

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer

Official Title

Randomized, Controlled Trial of an Electronic Decision Aid for Genetic Testing in Inherited Cancer Syndromes

Quick Facts

Study Start:2022-10-14
Study Completion:2025-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05470920

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years or older
  2. * Being seen in clinic at Massachusetts General Hospital or Boston Medical Center
  3. * Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma.
  4. * Unable or unwilling to provide informed consent, undergo randomization, or complete the surveys associated with the study
  5. * Previous germline genetic testing
  6. * History of hereditary pancreatitis
  7. * Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Daniel C. Chung, MD
CONTACT
(617) 726-8687
Chung.daniel@mgh.harvard.edu
Danielle A Lynch, BS
CONTACT
(617) 726-1355
dlynch22@mgh.harvard.edu

Principal Investigator

Daniel C. Chung, MD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02115
United States
Mass General at North Shore Cancer Center
Danvers, Massachusetts, 01923
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Daniel C. Chung, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-14
Study Completion Date2025-10-31

Study Record Updates

Study Start Date2022-10-14
Study Completion Date2025-10-31

Terms related to this study

Keywords Provided by Researchers

  • pancreas adenocarcinoma.
  • epithelial ovarian carcinoma
  • decision aid
  • inherited cancer syndrome
  • genetic testing

Additional Relevant MeSH Terms

  • Epithelial Ovarian Carcinoma
  • Pancreas Adenocarcinoma